rs7193297

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_006885.4(ZFHX3):​c.214T>G​(p.Ser72Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 1,596,348 control chromosomes in the GnomAD database, including 140,363 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars). Synonymous variant affecting the same amino acid position (i.e. S72S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.48 ( 18891 hom., cov: 32)
Exomes 𝑓: 0.40 ( 121472 hom. )

Consequence

ZFHX3
NM_006885.4 missense

Scores

1
17

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 1.63

Publications

35 publications found
Variant links:
Genes affected
ZFHX3 (HGNC:777): (zinc finger homeobox 3) This gene encodes a transcription factor with multiple homeodomains and zinc finger motifs, and regulates myogenic and neuronal differentiation. The encoded protein suppresses expression of the alpha-fetoprotein gene by binding to an AT-rich enhancer motif. The protein has also been shown to negatively regulate c-Myb, and transactivate the cell cycle inhibitor cyclin-dependent kinase inhibitor 1A (also known as p21CIP1). This gene is reported to function as a tumor suppressor in several cancers, and sequence variants of this gene are also associated with atrial fibrillation. Multiple transcript variants expressed from alternate promoters and encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
ZFHX3 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • syndromic complex neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Broad Center for Mendelian Genomics
  • spinocerebellar ataxia type 4
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • epilepsy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.6056085E-6).
BP6
Variant 16-72959932-A-C is Benign according to our data. Variant chr16-72959932-A-C is described in ClinVar as Benign. ClinVar VariationId is 3060596.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.695 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZFHX3NM_006885.4 linkc.214T>G p.Ser72Ala missense_variant Exon 2 of 10 ENST00000268489.10 NP_008816.3 Q15911-1Q8N2Y6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZFHX3ENST00000268489.10 linkc.214T>G p.Ser72Ala missense_variant Exon 2 of 10 1 NM_006885.4 ENSP00000268489.5 Q15911-1
ZFHX3ENST00000397992.5 linkc.-23-8967T>G intron_variant Intron 1 of 8 1 ENSP00000438926.3 Q15911-2
ZFHX3ENST00000641206.2 linkc.214T>G p.Ser72Ala missense_variant Exon 10 of 18 ENSP00000493252.1 Q15911-1

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72249
AN:
151772
Hom.:
18856
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.701
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.357
Gnomad EAS
AF:
0.260
Gnomad SAS
AF:
0.457
Gnomad FIN
AF:
0.467
Gnomad MID
AF:
0.366
Gnomad NFE
AF:
0.404
Gnomad OTH
AF:
0.425
GnomAD2 exomes
AF:
0.387
AC:
87536
AN:
225974
AF XY:
0.390
show subpopulations
Gnomad AFR exome
AF:
0.700
Gnomad AMR exome
AF:
0.222
Gnomad ASJ exome
AF:
0.328
Gnomad EAS exome
AF:
0.265
Gnomad FIN exome
AF:
0.447
Gnomad NFE exome
AF:
0.395
Gnomad OTH exome
AF:
0.368
GnomAD4 exome
AF:
0.404
AC:
583292
AN:
1444458
Hom.:
121472
Cov.:
80
AF XY:
0.405
AC XY:
290190
AN XY:
716784
show subpopulations
African (AFR)
AF:
0.713
AC:
23604
AN:
33094
American (AMR)
AF:
0.238
AC:
10225
AN:
43018
Ashkenazi Jewish (ASJ)
AF:
0.336
AC:
8453
AN:
25142
East Asian (EAS)
AF:
0.239
AC:
9412
AN:
39314
South Asian (SAS)
AF:
0.454
AC:
38142
AN:
83948
European-Finnish (FIN)
AF:
0.462
AC:
23989
AN:
51972
Middle Eastern (MID)
AF:
0.363
AC:
2063
AN:
5688
European-Non Finnish (NFE)
AF:
0.402
AC:
442883
AN:
1102712
Other (OTH)
AF:
0.412
AC:
24521
AN:
59570
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
23099
46198
69296
92395
115494
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13910
27820
41730
55640
69550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.476
AC:
72335
AN:
151890
Hom.:
18891
Cov.:
32
AF XY:
0.472
AC XY:
35022
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.701
AC:
29060
AN:
41436
American (AMR)
AF:
0.316
AC:
4826
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.357
AC:
1237
AN:
3468
East Asian (EAS)
AF:
0.260
AC:
1328
AN:
5116
South Asian (SAS)
AF:
0.457
AC:
2186
AN:
4788
European-Finnish (FIN)
AF:
0.467
AC:
4945
AN:
10582
Middle Eastern (MID)
AF:
0.346
AC:
101
AN:
292
European-Non Finnish (NFE)
AF:
0.404
AC:
27414
AN:
67926
Other (OTH)
AF:
0.427
AC:
896
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1818
3636
5455
7273
9091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
17708
Bravo
AF:
0.470
TwinsUK
AF:
0.396
AC:
1470
ALSPAC
AF:
0.407
AC:
1567
ESP6500AA
AF:
0.676
AC:
2955
ESP6500EA
AF:
0.371
AC:
3183
ExAC
AF:
0.365
AC:
43062
Asia WGS
AF:
0.397
AC:
1375
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

ZFHX3-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
8.1
DANN
Benign
0.82
DEOGEN2
Benign
0.091
T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.060
.;T
MetaRNN
Benign
0.0000036
T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
1.6
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.44
N;.
REVEL
Benign
0.21
Sift
Benign
1.0
T;.
Sift4G
Benign
0.61
T;.
Polyphen
0.0060
B;B
Vest4
0.030
MPC
0.078
ClinPred
0.0057
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.088
gMVP
0.035
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7193297; hg19: chr16-72993831; COSMIC: COSV51707067; API